Evidence-Based Practice: Temozolomide Beyond Glioblastoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11912-019-0783-5.pdf
Reference73 articles.
1. • Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J med. 2005;352:987–96. https://doi.org/10.1056/NEJMoa043330 This study demonstrated, both clinically and statistically, significant survival benefit with the addition of temozolomide to radiotherapy for glioblastoma, without significant toxicity. This has now become the standard of care following maximal safe surgical resection.
2. Hart MG, Garside R, Rogers G, Stein K, Grant R. Temozolomide for high grade glioma. Cochrane Database Syst Rev. 2013:Cd007415. https://doi.org/10.1002/14651858.CD007415.pub2 .
3. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev. 1997;23:35–61.
4. Agarwala SS, Kirkwood JM. Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist. 2000;5:144–51.
5. Brindley CJ, Antoniw P, Newlands ES. Plasma and tissue disposition of mitozolomide in mice. Br J Cancer. 1986;53:91–7.
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent in vitro models and tissue engineering strategies to study glioblastoma;Biotech Studies;2024-06-30
2. Stemness subtypes in lower-grade glioma with prognostic biomarkers, tumor microenvironment, and treatment response;Scientific Reports;2024-06-26
3. Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma;Translational Cancer Research;2024-01
4. Decoding Diffuse Midline Gliomas: A Comprehensive Review of Pathogenesis, Diagnosis and Treatment;Cancers;2023-10-06
5. Drug-Loaded Lipid Magnetic Nanoparticles for Combined Local Hyperthermia and Chemotherapy against Glioblastoma Multiforme;ACS Nano;2023-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3